CLYBL and colorectal carcinoma: Subsequent studies have shown that these clb+ strains are more prevalent in the gut microbiota of patients with inflammatory bowel disease, familial adenomatous polyposis, and CRC, implicating colibactin as a microbiome-derived carcinogenic agent under chronic inflammatory conditions [2, 3].